Cbd Thc Ratio Markers

CBD-to-THC ratio markers refer to genetic and biochemical indicators that influence the relative abundance of cannabidiol (CBD) and tetrahydrocannabinol (THC) in cannabis plants. These markers are determined by allelic variation in key biosynthetic enzymes, particularly CBDA synthase and THCA synthase, which direct precursor cannabinoids toward either the CBD or THC pathway. Breeders and researchers use ratio markers to identify and stabilize plants that produce balanced, CBD-dominant, or THC-dominant chemotypes. Understanding these genetic markers has become fundamental to modern cannabis breeding programs seeking predictable cannabinoid outcomes. Ratio stability across generations depends on homozygosity at loci controlling cannabinoid synthase expression.

Breeders use CBD-THC ratio markers as selection criteria to develop stable cultivars for specific cannabinoid profiles without relying solely on phenotypic testing. Marker-assisted selection (MAS) allows early identification of plants carrying desired ratio alleles, reducing breeding cycles and improving chemotype consistency across seed lots.